Reuters: Hot Stocks: BRIEF-Peregrine Pharma drops in premarket after discrepancies discovered in bavituximab trial data

Reuters: Hot Stocks Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

BRIEF-Peregrine Pharma drops in premarket after discrepancies discovered in bavituximab trial data Sep 24th 2012, 12:03 NEW YORK, Sept 24 | Mon Sep 24, 2012 8:03am EDT NEW YORK, Sept 24 (Reuters) - Peregrine Pharmaceuticals Inc : * Pharma drops 71.2 percent to $1.55 in premarket after discrepancies discovered in bavituximab trial data

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions